Recellularization of xenograft heart valves reduces the xenoreactive immune response in anin vivorat model
- 11 October 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 61 (2), 427-436
- https://doi.org/10.1093/ejcts/ezab439
Abstract
Our aim was to address the role of autologous mesenchymal stem cell recellularization of xenogenic valves on the activation of the xenoreactive immune response in an in vivo rat model. Explanted aortic valve constructs from female Hartley guinea pigs were procured and decellularized, followed by recellularization with autologous Sprague-Dawley rat mesenchymal stem cells. Aortic valve xenografts were then implanted into the infrarenal aorta of recipient rats. Grafts were implanted as either autologous grafts, non-decellularized (NGP), decellularized and recellularized xenografts (RGP). Rats were euthanized after 7 and 21 days and exsanguinated and the grafts were explanted. The NGP grafts demonstrated significant burden of granulocytes (14.3 cells/HPF) and CD3+ T cells (3.9 cells/HPF) compared to the autologous grafts (2.1 granulocytes/HPF and 0.72 CD3+ T cells/HPF) after 7 days. A lower absolute number of infiltrating granulocytes (NGP vs autologous, 6.4 vs 2.4 cells/HPF) and CD3+ T cells (NGP vs autologous, 2.8 vs 0.8 cells/HPF) was seen after 21 days. Equivalent granulocyte cell infiltration in the RGP grafts (2.4 cells/HPF) compared to the autologous grafts (2.1 cells/HPF) after 7 and 21 days (2.8 vs 2.4 cells/HPF) was observed. Equivalent CD3+ T-cell infiltration in the RGP grafts (0.63 cells/HPF) compared to the autologous grafts (0.72 cells/HPF) after 7 and 21 days (0.7 vs 0.8 cells/HPF) was observed. Immunoglobulin production was significantly greater in the NGP grafts compared to the autologous grafts at 7 (123.3 vs 52.7 mg/mL) and 21 days (93.3 vs 71.6 mg/mL), with a similar decreasing trend in absolute production. Equivalent immunoglobulin production was observed in the RGP grafts compared to the autologous grafts at 7 (40.8 vs 52.7 mg/mL) and 21 days (29.5 vs 71.6 mg/mL). Autologous mesenchymal stem cell recellularization of xenogenic valves reduces the xenoreactive immune response in an in vivo rat model and may be an effective approach to decrease the progression of xenograft valve dysfunction.Keywords
Funding Information
- University Hospital Foundation, Edmonton, Alberta
- Edmonton Civic Employees Charitable Assistance Fund
This publication has 27 references indexed in Scilit:
- Adverse results of a decellularized tissue-engineered pulmonary valve in humans assessed with magnetic resonance imagingEuropean Journal of Cardio-Thoracic Surgery, 2013
- Isolation and Enrichment of Rat Mesenchymal Stem Cells (MSCs) and Separation of Single-colony Derived MSCsJournal of Visualized Experiments, 2010
- Mid-Term Clinical Results Using a Tissue-Engineered Pulmonary Valve to Reconstruct the Right Ventricular Outflow Tract During the Ross ProcedureThe Annals of Thoracic Surgery, 2007
- Glutaraldehyde-Fixed Bioprosthetic Heart Valve Conduits Calcify and Fail From Xenograft RejectionJournal of the American College of Cardiology, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Decellularization reduces the immune response to aortic valve allografts in the ratThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Human mesenchymal stem cells modulate allogeneic immune cell responsesBlood, 2005
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- CELL AND EXTRACELLULAR MATRIX REJECTION IN ARTERIAL CONCORDANT AND DISCORDANT XENOGRAFTS IN THE RAT1Transplantation, 1996
- SEQUENTIAL IMMUNOLOGICAL TARGETING OF CHRONIC EXPERIMENTAL ARTERIAL ALLOGRAFTTransplantation, 1995